{"disease":{"id":"thymic-epithelial-tumor","name":"thymic epithelial tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02146170","title":"Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06421805","title":"Establishing Prospective Mediastinal Tumor Database of PUMCH","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06301945","title":"Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":1020,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT05667948","title":"Molecular Analysis and Treatment Options of Thymic Malignancies","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false},{"nct_id":"NCT07383142","title":"Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":202,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT06692062","title":"Hypofractionated Radiotherapy for Thymic Epithelial Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Rongrong Zhou","has_results":false},{"nct_id":"NCT06654830","title":"RATT Vs. VATT for Early-stage TETs","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT04517539","title":"Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":65,"lead_sponsor_name":"Shanghai Cancer Hospital, China","has_results":false},{"nct_id":"NCT03212027","title":"Preoperative Prediction of of Thymic Epithelial Tumors by Diffusion-Weighted MR Imaging","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Tang-Du Hospital","has_results":false},{"nct_id":"NCT05104736","title":"PT-112 in Subjects With Thymoma and Thymic Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":53,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06311955","title":"Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Jian Chen","has_results":false},{"nct_id":"NCT06200233","title":"Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT03858582","title":"neoadjuvant_thymic Epithelial Tumor","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT07343453","title":"A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":38,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05446935","title":"Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence","phase":"NA","overall_status":"UNKNOWN","enrollment_count":37,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT04667793","title":"Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false},{"nct_id":"NCT04417660","title":"Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03193437","title":"Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Georgetown University","has_results":true}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}